LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

AngioDynamics, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERANGO
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / ANGO COVERAGE

What’s moving AngioDynamics, Inc. now

Current reporting with the operating signal separated from the noise.

01
AngioDynamics, Inc. (ANGO) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Prepared Remarks Transcript

AngioDynamics, Inc. (ANGO) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Prepared Remarks Transcript

The story matters when it changes AngioDynamics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest ANGO filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-04-02 · Period 2026-02-28SEC ↗10-QQuarterly financial reportFiled 2026-01-06 · Period 2025-11-30SEC ↗10-KAnnual financial reportFiled 2026-07-14 · Period 2026-05-31SEC ↗8-KMaterial company eventFiled 2026-07-14 · Period 2026-07-14SEC ↗8-KMaterial company eventFiled 2026-04-23 · Period 2026-04-23SEC ↗8-KMaterial company eventFiled 2026-04-02 · Period 2026-04-02SEC ↗DEF 14AProxy and shareholder meetingFiled 2025-09-25 · Period 2025-05-31SEC ↗4Official SEC filingFiled 2026-07-31 · Period 2026-07-30SEC ↗
EARNINGS / QUARTERLY TRACKER

AngioDynamics, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.